• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    63.37 Up 2.22(3.63%) Mar 27, 4:00PM EDT
    |After Hours : 63.43 Up 0.06 (0.09%) Mar 27, 7:33PM EDT
    Add to Portfolio
    Prev Close:61.15
    Open:61.57
    Bid:63.25 x 100
    Ask:63.58 x 100
    1y Target Est:65.80
    Beta:1.09
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:61.41 - 64.44
    52wk Range:22.25 - 77.80
    Volume:4,336,080
    Avg Vol (3m):3,298,150
    Market Cap:7.54B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISUp 3.63%7.54B
    ENZDown 4.00%130.68M
    GILDDown 0.07%150.43B
    SRPTUp 3.83%560.59M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.82
    Quarterly EPS Est (Mar-15) :-0.21
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-4.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback